Stephen D. Ginsberg

13.5k total citations · 2 hit papers
184 papers, 10.3k citations indexed

About

Stephen D. Ginsberg is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stephen D. Ginsberg has authored 184 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Physiology, 75 papers in Molecular Biology and 51 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stephen D. Ginsberg's work include Alzheimer's disease research and treatments (80 papers), Neuroscience and Neuropharmacology Research (31 papers) and Down syndrome and intellectual disability research (30 papers). Stephen D. Ginsberg is often cited by papers focused on Alzheimer's disease research and treatments (80 papers), Neuroscience and Neuropharmacology Research (31 papers) and Down syndrome and intellectual disability research (30 papers). Stephen D. Ginsberg collaborates with scholars based in United States, Canada and France. Stephen D. Ginsberg's co-authors include Elliott J. Mufson, Scott Counts, Shaoli Che, Sylvia E. Perez, Melissa J. Alldred, Melissa J. Alldred, Scott E. Hemby, James Eberwine, Miloš D. Ikonomović and John Q. Trojanowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Investigation.

In The Last Decade

Stephen D. Ginsberg

180 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease

2020 320 citations Virginia M.‐Y. Lee, John Q. Trojanowski et al. profile →
Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome

2021 195 citations Pasquale D’Acunzo, Melissa J. Alldred et al. profile →

Peers

Stephen D. Ginsberg

PHYSI

MB

CMN

NEURO

PHARM

Jerzy Węgiel United States

Jacob Raber United States

David F. Wozniak United States

Christian J. Pike United States

Stuart Maudsley United States

Gábor G. Kovács Austria

Neil W. Kowall United States

Frédéric Calon Canada

Scott A. Small United States

Bronwen Martin United States

Jerzy Węgiel United States

Stephen D. Ginsberg

4.5k ×1.0

PHYSI

3.2k ×0.8

MB

1.3k ×0.5

CMN

1.6k ×0.9

NEURO

767 ×0.7

PHARM

Citations per year, relative to Stephen D. Ginsberg Stephen D. Ginsberg (= 1×) peers Jerzy Węgiel

Countries citing papers authored by Stephen D. Ginsberg

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Ginsberg more than expected).

Fields of papers citing papers by Stephen D. Ginsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Ginsberg. The network helps show where Stephen D. Ginsberg may publish in the future.

Co-authorship network of co-authors of Stephen D. Ginsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Ginsberg. A scholar is included among the top collaborators of Stephen D. Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Ginsberg. Stephen D. Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Counts, Scott, John S. Beck, Bryan Maloney, et al.. (2025). Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease. Alzheimer s & Dementia. 21(2). e70019–e70019. 2 indexed citations

2.

Chu, Feixia, Sahil Sharma, Stephen D. Ginsberg, & Gabriela Chiosis. (2025). PTMs as molecular encoders: reprogramming chaperones into epichaperomes for network control in disease. Trends in Biochemical Sciences. 50(10). 892–905. 1 indexed citations

3.

D’Acunzo, Pasquale, Monika Pawlik, Adriana Heguy, et al.. (2024). Apolipoprotein E2 Expression Alters Endosomal Pathways in a Mouse Model With Increased Brain Exosome Levels During Aging. Traffic. 25(5). e12937–e12937. 2 indexed citations

4.

Ginsberg, Stephen D. & Martin J. Blaser. (2024). Alzheimer's Disease Has Its Origins in Early Life via a Perturbed Microbiome. The Journal of Infectious Diseases. 230(Supplement_2). S141–S149. 2 indexed citations

5.

Zhu, Biqing, Anthony J. Russo, Jiawei Wang, et al.. (2024). Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains. Science Translational Medicine. 16(771). eabo1997–eabo1997. 16 indexed citations

6.

Leary, Paige, John J. LaFrancois, David Alcantara‐Gonzalez, et al.. (2024). Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer’s disease. eLife. 12. 3 indexed citations

7.

Leary, Paige, John J. LaFrancois, David Alcantara‐Gonzalez, et al.. (2024). Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer’s disease. eLife. 12. 2 indexed citations

8.

Kelley, Christy M., Sang H. Lee, Melissa J. Alldred, et al.. (2023). Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Neurobiology of Disease. 188. 106332–106332. 12 indexed citations

9.

Ginsberg, Stephen D., et al.. (2021). The penalty of stress ‐ Epichaperomes negatively reshaping the brain in neurodegenerative disorders. Journal of Neurochemistry. 159(6). 958–979. 21 indexed citations

10.

Cox, Laura M., Marissa J. Schafer, Jiho Sohn, et al.. (2019). Calorie restriction slows age-related microbiota changes in an Alzheimer’s disease model in female mice. Scientific Reports. 9(1). 17904–17904. 111 indexed citations

11.

Henderson, Michael X., Stephen D. Ginsberg, Natalia Dolzhanskaya, et al.. (2015). Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation. Acta Neuropathologica. 131(4). 621–637. 63 indexed citations

12.

Zhang, Yongquan, Michael X. Henderson, Christopher M. Colangelo, et al.. (2012). Identification of CSPα Clients Reveals a Role in Dynamin 1 Regulation. Neuron. 74(1). 136–150. 75 indexed citations

13.

Alldred, Melissa J., Karen Duff, & Stephen D. Ginsberg. (2011). Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiology of Disease. 45(2). 751–762. 51 indexed citations

14.

Levine, Seymour, Arthur Saltzman, & Stephen D. Ginsberg. (2011). Vacuolar Pathology in the Median Eminence of the Hypothalamus After Hyponatremia. Journal of Neuropathology & Experimental Neurology. 70(2). 151–156. 5 indexed citations

15.

Haskew-Layton, Renee, N. A. Smirnova, C. Thong, et al.. (2010). Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proceedings of the National Academy of Sciences. 107(40). 17385–17390. 127 indexed citations

16.

Altar, C. Anthony, Marquis P. Vawter, & Stephen D. Ginsberg. (2008). Target Identification for CNS Diseases by Transcriptional Profiling. Neuropsychopharmacology. 34(1). 18–54. 121 indexed citations

17.

Ginsberg, Stephen D.. (2008). Transcriptional Profiling of Small Samples in the Central Nervous System. Methods in molecular biology. 439. 147–158. 36 indexed citations

18.

Ginsberg, Stephen D., Marc D. Ruben, Scott Counts, et al.. (2004). Single-Cell Gene Expression Analysis: Implications for Neurodegenerative and Neuropsychiatric Disorders. Neurochemical Research. 29(6). 1053–1064. 76 indexed citations

19.

Ginsberg, Stephen D., et al.. (1998). RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathologica. 96(5). 487–494. 106 indexed citations

20.

Ginsberg, Stephen D., Peter B. Crino, Virginia M.‐Y. Lee, James Eberwine, & John Q. Trojanowski. (1997). Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Annals of Neurology. 41(2). 200–209. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact